Senior Director

Bryant Yan, corresponding author, is a Sr. Director at Acceleron Pharma, in charge of analytical development and quality control within technical operation. Byan@acceleronpharma.com, 1-617 649-9237, www.acceleronpharma.com.

Bryant Yan

Radical Induced Hinge Degradation of Human IgG1 Antibody
Tuesday, April 21, 2020
The monoclonal antibodies (mAbs) market has changed rapidly in the past five years, with mAbs representing more than 50% of the overall biotherapeutic market. Now, speed to clinic is a huge determinant of success, much of the... read more